Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Menza

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Neurology|April 3, 2020
Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trialRoseanne D Dobkin, Sarah L Mann, Michael A Gara, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 15, 2009
Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot studyRoseanne Defronzo Dobkin, Matthew Menza, Lesley A Allen, et al.
Psychiatric Services (Washington, D.C.)|June 7, 2006
Efficacy of the team solutions program for educating patients about illness management and treatmentBetty Vreeland, Shula Minsky, Philip T Yanos, et al.
Psychosomatics|November 6, 2010
The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's diseaseMatthew Menza, Roseanne Defronzo Dobkin, Humberto Marin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's diseaseMatthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's diseaseRoseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, et al.
Journal of Consulting and Clinical Psychology|March 14, 2012
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's diseaseRoseanne D Dobkin, Jade Tiu Rubino, Lesley A Allen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic managementRoseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 27, 2013
Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's diseaseRoseanne D Dobkin, Alexander I Tröster, Jade Tiu Rubino, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2010
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placeboMatthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Neurology|April 3, 2020
Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trialRoseanne D Dobkin, Sarah L Mann, Michael A Gara, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 15, 2009
Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot studyRoseanne Defronzo Dobkin, Matthew Menza, Lesley A Allen, et al.
Psychiatric Services (Washington, D.C.)|June 7, 2006
Efficacy of the team solutions program for educating patients about illness management and treatmentBetty Vreeland, Shula Minsky, Philip T Yanos, et al.
Psychosomatics|November 6, 2010
The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's diseaseMatthew Menza, Roseanne Defronzo Dobkin, Humberto Marin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's diseaseMatthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's diseaseRoseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, et al.
Journal of Consulting and Clinical Psychology|March 14, 2012
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's diseaseRoseanne D Dobkin, Jade Tiu Rubino, Lesley A Allen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic managementRoseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 27, 2013
Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's diseaseRoseanne D Dobkin, Alexander I Tröster, Jade Tiu Rubino, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2010
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placeboMatthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, et al.
Pageof 4